Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-21-013314
Filing Date
2021-12-17
Accepted
2021-12-17 09:30:48
Documents
1
Period of Report
2021-12-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-54703.html 4  
1 PRIMARY DOCUMENT marketforms-54703.xml 4 3097
  Complete submission text file 0001214659-21-013314.txt   4446
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Issuer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11 SUMMIT LANE GREENVILLE DE 19807
Business Address
Grant Stuart M. (Reporting) CIK: 0001783415 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38365 | Film No.: 211499846